Psychiatr Serv 53:842-847, July 2002
© 2002 American Psychiatric Association
Body Weight Changes Associated With Psychopharmacology
Yelena Vanina, M.D.,
Anna Podolskaya, M.D.,
Karim Sedky, M.D.,
Hasan Shahab, M.D.,
Abufarah Siddiqui, M.D.,
Firoz Munshi, M.D. and
Steven Lippmann, M.D.
OBJECTIVE: The authors discuss changes in body weight associated with various psychopharmaceuticals. METHODS: A large number of articles and books about drug-induced changes in body weight, selected on the basis of various literature searches and the authors' clinical experiences with psychopharmaceuticals, were reviewed. RESULTS: Many psychotropic drugs with antipsychotic, mood stabilizing, and antidepressant properties are associated with weight gain. Others, such as fluoxetine, isocarboxazid, nefazadone, topiramate, and psychostimulants, may cause weight loss. The antipsychotic drugs chlorpromazine, clozapine, and olanzapine are often associated with weight gain. Among antidepressants, amitriptyline and mirtazapine are known to cause weight gain. However, reductions are sometimes observed, and each antidepressant has its own unique weight-effect profile. Mood stabilizers, especially valproate-related products, are also associated with weight gain. CONCLUSIONS: Careful monitoring and consideration of alternative therapies are essential.
This article has been cited by other articles:
|
|
|
|
 
M. Bigal, R. Lipton, D. Biondi, J Xiang, and J Hulihan
Weight Change and Clinical Markers of Cardiovascular Disease Risk During Preventive Treatment of Migraine
Cephalalgia,
November 1, 2009;
29(11):
1188 - 1196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Blaine
Does Depression Cause Obesity?: A Meta-analysis of Longitudinal Studies of Depression and Weight Control
J Health Psychol,
November 1, 2008;
13(8):
1190 - 1197.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Park, S. Hong, J. Lee, S. Sung, and S. Kim
Chlorpromazine attenuates pancreatic {beta}-cell function and mass through IRS2 degradation, while exercise partially reverses the attenuation
J Psychopharmacol,
July 1, 2008;
22(5):
522 - 531.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Kisely, M. Smith, D. Lawrence, M. Cox, L. A. Campbell, and S. Maaten
Inequitable access for mentally ill patients to some medically necessary procedures
Can. Med. Assoc. J.,
March 13, 2007;
176(6):
779 - 784.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Huizinga and A. Peltier
Painful Diabetic Neuropathy: A Management-Centered Review
Clin. Diabetes,
January 1, 2007;
25(1):
6 - 15.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Collazo-Clavell, M. M. Clark, D. E. McAlpine, and M. D. Jensen
Assessment and Preparation of Patients for Bariatric Surgery
Mayo Clin. Proc.,
October 1, 2006;
81(10_Suppl):
S11 - S17.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kisely, M. Smith, D. Lawrence, and S. Maaten
Mortality in individuals who have had psychiatric treatment: Population-based study in Nova Scotia
The British Journal of Psychiatry,
December 1, 2005;
187(6):
552 - 558.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Berilgen, S Bulut, M Gonen, A Tekatas, E Dag, and B Mungen
Comparison of the Effects of Amitriptyline and Flunarizine on Weight Gain and Serum Leptin, C Peptide and Insulin Levels when used as Migraine Preventive Treatment
Cephalalgia,
November 1, 2005;
25(11):
1048 - 1053.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Kennedy, P. Salsberry, J. Nickel, C. Hunt, and E. Chipps
The Burden of Disease in Those With Serious Mental and Physical Illnesses
Journal of the American Psychiatric Nurses Association,
February 1, 2005;
11(1):
45 - 51.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. C. Lagace and M. W. Nachtigal
Inhibition of Histone Deacetylase Activity by Valproic Acid Blocks Adipogenesis
J. Biol. Chem.,
April 30, 2004;
279(18):
18851 - 18860.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. P. Richardson, R. Davis, R. Poulton, E. McCauley, T. E. Moffitt, A. Caspi, and F. Connell
A Longitudinal Evaluation of Adolescent Depression and Adult Obesity
Arch Pediatr Adolesc Med,
August 1, 2003;
157(8):
739 - 745.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Rosack
New Studies Raise Questions About Antipsychotic Efficacy
Psychiatr News,
July 4, 2003;
38(13):
18 - 19.
[Full Text]
|
|
|
|
|
|
|
S. Garattini, V. Bertele, and L. L. Bassi
How can research ethics committees protect patients better?
BMJ,
May 29, 2003;
326(7400):
1199 - 1201.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Altering Minds, Altering Bodies
Journal Watch Women's Health,
September 24, 2002;
2002(924):
6 - 6.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
